COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 493: Articles 4921-4930  | Next

COVID-19 and Health System Response for Management of Diabetes in Bangladesh: A national qualitative study of patients with diabetes and key healthcare professionals/policy makers
Talukder, S. H., Islam, T., Salahin, K. F., Akter, S., Farhana, D., Sultana, U. F., Shariful Islam, S. M., Shi, Z., Hussain, A., Godman, B., Kurdi, A.
10.1101/2022.12.18.22283405 — Posted: 2022-12-20
ACE-2-like enzymatic activity is associated with immunoglobulin in COVID-19 patients
Song, Y., Myers, R., Murphy, L., Brooks, B., Wilson, J. M., Kadl, A., Woodfolk, J. A., Zeichner, S. L.
10.1101/2022.12.19.22283685 — Posted: 2022-12-20
coronabambini.ch: Development and usage of an online decision support tool for pediatric COVID-testing in Switzerland: a cross-sectional analysis
Starvaggi, C., Travaglini, N., Aebi, C., Romano, F., Steiner, I., Sauter, T. C., Keitel, K.
10.1101/2022.12.19.22283560 — Posted: 2022-12-20
Analysis of uptake, effectiveness and safety of COVID-19 vaccinations in pregnancy using the QResearch database: research protocol and statistical analysis plan
Copland, E., Hirst, J. A., Ranger, T., Mei, W. X., Dixon, S., Coupland, C., Hodson, K., Richardson, J. L., Harnden, A., Sheikh, A., Dezateux, C., Kelly, B., Knight, M., Van Tam, J., Morelli, A., Enstone, J., Hippisley-Cox, J.
10.1101/2022.12.19.22283660 — Posted: 2022-12-19
Transgenic Mouse Models Establish a Protective Role of Type 1 IFN Response in SARS-CoV-2 infection-related Immunopathology
Chauhan, N. R., Kundu, S., Bal, R., Chattopadhyay, D., Mehto, S., Sahu, R., Yadav, R., Krishna, S., Jena, K. K., Satapathy, S., Murmu, K. C., Singh, B., Das, S. K., Jena, S., Harshan, K. H., Syed, G. H., Prasad, P., Chauhan, S.
10.1101/2022.12.17.520843 — Posted: 2022-12-19
A retrospective analysis of COVID-19 non-pharmaceutical interventions for Mexico and Peru: a modeling study
Acuna-Zegarra, M. A., Santana-Cibrian, M., Rodriguez Hernandez-Vela, C. E., Mena, R. H., Velasco-Hernandez, J. X.
10.1101/2022.12.19.22283668 — Posted: 2022-12-19
Association between SARS-CoV-2 Infection and Select Symptoms and Conditions 31 to 150 Days After Testing among Children and Adults
Zhang, Y., Romieu-Hernandez, A., Boehmer, T. K., Azziz-Baumgartner, E., Carton, T., Gundlapalli, A. V., Fearrington, J., Nagavedu, K., Dea, K., Moyneur, E., Cowell, L. G., Kaushal, R., Mayer, K. H., Puro, J., Rasmussen, S. A., Thacker, D., Weiner, M. G., Saydeh, S., Block, J. P.
10.1101/2022.12.18.22283646 — Posted: 2022-12-19
Effectiveness of the Coronavirus Disease 2019 (COVID-19) Bivalent Vaccine
Shrestha, N. K., Burke, P. C., Nowacki, A. S., Simon, J. F., Hagen, A., Gordon, S. M.
10.1101/2022.12.17.22283625 — Posted: 2022-12-19
Digital PCR discriminates between SARS-CoV-2 Omicron variants and immune escape mutations
Holland, S. C., Holland, L. A., Smith, M. F., Lee, M. B., Hu, J. C., Lim, E. S.
10.1101/2022.12.19.22283598 — Posted: 2022-12-19
How SARS-CoV-2 alters the regulation of gene expression in infected cells.
Bignon, E., Grandemange, S., Dumont, E., Monari, A.
10.1101/2022.12.18.520908 — Posted: 2022-12-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).